Premium Nahrungsergänzungsmittel | artgerecht

Akkermansia muciniphila – Gut Bacteria and Health

Akkermansia muciniphila is a gut bacterium that plays a key role in intestinal health and immune regulation, attracting growing interest in medical research.

Regular tips about health Regular tips about health

Things worth knowing about "Akkermansia muciniphila"

Akkermansia muciniphila is a gut bacterium that plays a key role in intestinal health and immune regulation, attracting growing interest in medical research.

What is Akkermansia muciniphila?

Akkermansia muciniphila is a gram-negative, anaerobic bacterium that naturally inhabits the human gut. It belongs to the phylum Verrucomicrobia and was first described in 2004 by Muriel Derrien and colleagues. Its name is derived from the Latin word for mucus, as this bacterium uses the mucosal lining of the intestine as its primary nutrient source. Akkermansia muciniphila is considered an important component of a healthy gut microbiome and can account for up to 4 percent of the total gut flora in healthy adults.

Mechanism of Action and Function

Akkermansia muciniphila interacts with the human body in several important ways:

Strengthening the gut barrier: The bacterium promotes mucus production and supports the integrity of the intestinal lining, helping to prevent increased intestinal permeability, often referred to as leaky gut.
Immune modulation: Akkermansia muciniphila positively influences both the innate and adaptive immune systems and can help reduce pro-inflammatory processes in the gut.
Metabolic regulation: Studies indicate that this bacterium has a beneficial effect on glucose and lipid metabolism and may play a role in body weight regulation.
Production of short-chain fatty acids: The breakdown of mucus by this bacterium yields short-chain fatty acids such as propionate and acetate, which serve as energy sources for intestinal cells.

Medical Significance and Research

Numerous clinical and preclinical studies have linked reduced levels of Akkermansia muciniphila in the gut to a range of health conditions:

Type 2 diabetes mellitus: Patients with type 2 diabetes often exhibit lower concentrations of this bacterium. Evidence suggests that increasing its abundance may improve insulin resistance.
Obesity and metabolic syndrome: Overweight individuals frequently show reduced levels of Akkermansia muciniphila. Animal studies and early human trials suggest that supplementation may positively influence body weight.
Inflammatory bowel diseases: In conditions such as Crohn's disease and ulcerative colitis, the abundance of this bacterium is often reduced, pointing to a potential protective role.
Cancer therapy: Emerging research suggests that Akkermansia muciniphila may enhance the response to immune checkpoint inhibitors, a form of cancer immunotherapy.
Neurological conditions: Preliminary evidence points to a possible link between altered Akkermansia levels and neurological conditions such as Parkinson's disease and multiple sclerosis, though further research is needed.

Akkermansia muciniphila as a Probiotic

Due to its wide-ranging beneficial properties, Akkermansia muciniphila is being discussed as a next-generation probiotic. In 2021, a pasteurized preparation (consisting of inactivated bacteria) received approval in Europe as a novel food by the European Food Safety Authority (EFSA). Clinical trials have demonstrated that both live and pasteurized forms of Akkermansia muciniphila are safe for use in humans and can achieve positive metabolic effects.

Supporting Natural Akkermansia Levels

Certain lifestyle factors can help maintain and support natural concentrations of Akkermansia muciniphila in the gut:

A diet rich in dietary fibre (e.g., legumes, whole grains, vegetables)
Foods high in polyphenols (e.g., berries, green tea, dark chocolate)
Regular physical activity
Avoiding excessive alcohol consumption and unnecessary antibiotic use

Safety and Risks

Based on current research, Akkermansia muciniphila is considered safe for healthy adults. No serious adverse effects have been reported in clinical trials. However, individuals who are immunocompromised or have a significantly compromised gut barrier should always consult a healthcare professional before taking any probiotic supplement.

References

Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucus-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology. 2004;54(5):1469-1476.
Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine. 2017;23(1):107-113.
Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine. 2019;25(7):1096-1103.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.